AwardedCzechiaGoodsCZK 67,350,000
Dodávky léků – Léčivá látka sacituzumab govitekan – ATC L01FX17
- Published
- Published 20 August 2025
- Deadline
- Closed 19 September 2025
Overview
LL-sacituzumab govitekan, léková forma 200MG INF PLV CSL, měrná jednotka 1x200MG, množství 5 000
Key details
- Country
- Czechia
- Status
- Awarded
- Category
- Goods
- Estimated value
- CZK 67,350,000
- Procedure
- Open
- SME suitable
- Yes
- Published
- 20 August 2025
- Deadline
- Closed
Antineoplastic agents
Award outcome
- Awarded value
- CZK 67,350,000
- Award date
- 24 September 2025
- Contract period
- 2 October 2025 → 11 September 2029
- Gilead Sciences s.r.o.
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
3 October 2025
Contract Notice
20 August 2025
Contracting authority
Fakultní Thomayerova nemocnice
Procuring entityPraha, Czechia
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.